🏥
🏥 Health
Intravenous vitamin C may damage cancer cells — new research shifts the picture
Researchers have found that intravenous vitamin C reaches far higher blood concentrations than oral supplements and can behave more like an experimental cancer drug. Early studies suggest it may damage vulnerable cancer cells, reduce treatment side effects and potentially improve outcomes for some patients. Previous clinical trials using vitamin C pills showed no benefit, leading to the dismissal of Linus Pauling's earlier claims.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!